Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Deloitte
US Department of Justice
Fuji
McKesson
AstraZeneca
Moodys
Boehringer Ingelheim

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 070295

« Back to Dashboard

NDA 070295 describes METRONIDAZOLE HYDROCHLORIDE, which is a drug marketed by Abraxis Pharm and is included in one NDA. Additional details are available on the METRONIDAZOLE HYDROCHLORIDE profile page.

The generic ingredient in METRONIDAZOLE HYDROCHLORIDE is metronidazole hydrochloride. There are eighteen drug master file entries for this compound. Additional details are available on the metronidazole hydrochloride profile page.
Summary for 070295
Tradename:METRONIDAZOLE HYDROCHLORIDE
Applicant:Abraxis Pharm
Ingredient:metronidazole hydrochloride
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 500MG BASE/VIAL
Approval Date:Oct 15, 1985TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Fuji
Colorcon
QuintilesIMS
Harvard Business School
Cantor Fitzgerald
US Army
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.